Sanofi And UCB To Discover And Develop AutoImmune Drugs

Sanofi and UCB have entered into a strategic and scientific partnership to try to discover and develop novel anti-inflammatory small molecules for potential treatment of a broad range of immune-mediated diseases.
Source: Pharmaceutical Online News - Category: Pharmaceuticals Source Type: news